Navigation Links
Amifostine Renders Cancer More Susceptible To Radiation

The drug amifostine has been found to ease most of the side affects associated with radiation therapy and also make cancer more susceptible to radiation, according to doctors in Brazil. Their findings are published in the March 1// issue of the International Journal of Radiation

Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology. The reserachers decided to check out data from already published studies to evaluate if adding amifostine to radiation therapy decreased the occurrence of side effects like difficulty in swallowing, dry mouth, lung inflammation, bladder inflammation, problems with the esophagus and inflammation of the mucous membranes. Sometimes these side effects cause significant problems and even force the treatment to be stopped while the patient recovers. The study also wanted to find out if amifostine protected the cancer from radiation. The researchers evaluated the effects of amifostine in 14 randomized, controlled trials in which 1,451 patients were enrolled. These patients were split into two groups, one receiving radiation alone, while the other received radiation as well as amifostine. It was found that contrary to fears, amifostine rendered the tumor more susceptible to radiation and patients on amifostine were more likely to have their cancer completely cured by radiation. But amifostine did have some side effects like nausea and vomiting. "Our research shows that adding amifostine to radiation therapy helps reduce side effects while at the same time making the radiation treatments more effective at killing the cancer cells," said Andre Deeke Sasse, M.D., a radiation oncologist at Nucleo Brasileiro de Oncologia Baseada em Evidencias in Sao Paolo, Brazil. "We recommend that patients undergoing radiation therapy for cancer ask their doctor about adding amifostine to their treatment." For more information on radiation therapy for cancer, please visit www.rtanswers.org. Contact: Nick Lashinsky nickl@astro.org 703-227-0185 American Society for Therapeutic Radiology and Oncology Source: Eurekalert
'"/>




Related medicine news :

1. Anthrax Spores: Animal Skins on Drums, Renders Vado Diomande, Sick
2. Fibroids unlikely to Turn Cancerous
3. Virus Level could Predict Cervical Cancer Risk
4. Cancer Doctors Okays Controversial Prostate Therapy
5. Potential New Cancer Gene Identified
6. Consensus on "Combination Therapy" for Breast Cancer
7. Cancers of Colon & Rectum linked to Cigarette Smoking
8. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
9. The Cancer Rumour mill working over time
10. Cancer drugs in development nearly doubled since 1995
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
Breaking Medicine Technology: